• Adherence to cancer screening guidelines in Australian survivors of allogeneic blood and marrow transplantation (BMT) 

      Dyer, G; Larsen, S.R; Gilroy, Nicole; Brice, Lisa; Greenwood, Matt; Hertzberg, Mark; Kabir, Masura; Brown, Louisa; Hogg, Megan; Huang, Gillian; Moore, John; Gottlieb, David; Kwan, John; Tan, Jeff; Ward, Christopher; Kerridge, I
      Published 2016-04-25
      Allogeneic Blood and Marrow Transplant (BMT) survivors are at high risk of secondary cancers. Although current guidelines endorse survivors following Country-specific general population screening recommendations to mitigate ...
      Open Access
      Article
    • PSA testing for men at average risk of prostate cancer. 

      Armstrong, B; Barry, M; Frydenberg, M; Gardiner, RA; Haines, I; Carter, SM
      Published 2017-01-01
      Prostate-specific antigen (PSA) testing of men at normal risk of prostate cancer is one of the most contested issues in cancer screening. There is no formal screening program, but testing is common - arguably a practice ...
      Open Access
      Article
    • Screening for cervical, prostate and breast cancer: interpreting the evidence 

      Carter, SM; Williams, J; Parker, Lisa; Pickles, K; Jacklyn, G; Rychetnik, L; Barratt, A
      Published 2015-06-01
      Cancer screening is well-established in high income countries, but its evidence base is constantly evolving and often contentious. This leaves physicians and policymakers in a difficult position, forced to act in the context ...
      Open Access
      Article
    • What is overdiagnosis and why should we take it seriously in cancer screening? 

      Carter, SM; Barratt, A
      Published 2017-07-01
      Overdiagnosis occurs in a population when conditions are diagnosed correctly but the diagnosis produces an unfavourable balance between benefits and harms. In cancer screening, overdiagnosed cancers are those that did not ...
      Open Access
      Article